Insider · CIK 0001690920
Crockett Thomas Andrew
Reports to the SEC for 1 company · SALISBURY, WILTSHIRE, X0
Transactions
50
Companies
1
Filings
8
CIK
0001690920
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-02-20 | KalVista Pharmaceuticals, Inc.S Sale | −$351K |
| 2024-02-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2024-02-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2024-02-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2024-02-17 | KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion | — |
| 2024-02-17 | KalVista Pharmaceuticals, Inc.Performance Stock UnitsM Exercise/Conversion | — |
| 2024-02-14 | KalVista Pharmaceuticals, Inc.S Sale | −$876K |
| 2024-02-11 | KalVista Pharmaceuticals, Inc.A Award | — |
| 2024-02-11 | KalVista Pharmaceuticals, Inc.Performance Stock UnitsA Award | — |
| 2024-02-01 | KalVista Pharmaceuticals, Inc.S Sale | −$150K |
| 2024-02-01 | KalVista Pharmaceuticals, Inc.S Sale | −$11.8K |
| 2023-12-27 | KalVista Pharmaceuticals, Inc.S Sale | −$360K |
| 2023-11-20 | KalVista Pharmaceuticals, Inc.S Sale | −$122K |
| 2023-11-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-11-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-11-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-11-17 | KalVista Pharmaceuticals, Inc.Performance Stock UnitM Exercise/Conversion | — |
| 2023-10-30 | KalVista Pharmaceuticals, Inc.G Gift | — |
| 2023-08-18 | KalVista Pharmaceuticals, Inc.S Sale | −$160K |
| 2023-08-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-08-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-08-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-08-17 | KalVista Pharmaceuticals, Inc.Performance Stock UnitM Exercise/Conversion | — |
| 2023-05-18 | KalVista Pharmaceuticals, Inc.S Sale | −$57.1K |
| 2023-05-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-05-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-05-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-02-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-02-17 | KalVista Pharmaceuticals, Inc.S Sale | −$51.3K |
| 2023-02-17 | KalVista Pharmaceuticals, Inc.Performance Restricted Stock UnitM Exercise/Conversion | — |
| 2023-02-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-02-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2023-01-11 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitA Award | — |
| 2022-11-18 | KalVista Pharmaceuticals, Inc.S Sale | −$9,710.4 |
| 2022-11-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2022-11-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2022-09-02 | KalVista Pharmaceuticals, Inc.S Sale | −$22.5K |
| 2022-08-17 | KalVista Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2022-08-17 | KalVista Pharmaceuticals, Inc.S Sale | −$26.9K |
| 2022-08-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion | — |
| 2022-07-02 | KalVista Pharmaceuticals, Inc.G Gift | — |
| 2022-05-17 | KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award | — |
| 2022-05-17 | KalVista Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2022-03-09 | KalVista Pharmaceuticals, Inc.S Sale | −$171K |
| 2021-10-01 | KalVista Pharmaceuticals, Inc.S Sale | −$172K |
| 2021-07-01 | KalVista Pharmaceuticals, Inc.S Sale | −$104K |
| 2021-07-01 | KalVista Pharmaceuticals, Inc.S Sale | −$138K |
| 2021-06-17 | KalVista Pharmaceuticals, Inc.S Sale | −$32.1K |
| 2021-06-09 | KalVista Pharmaceuticals, Inc.S Sale | −$268K |
| 2021-05-26 | KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Crockett Thomas Andrew0001415889-24-004710SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001415889-24-004120SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001415889-24-003475SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001415889-24-002625SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001209191-23-059907SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001209191-23-056267SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001209191-23-054018SEC(opens sec.gov)
- 4Crockett Thomas Andrew0001209191-23-046820SEC(opens sec.gov)
Companies
Address
C/O KALVISTA PHARMACEUTICALS, INC. BUILDING 227, TETRICUS SCIENCE PARK, POR
SALISBURY, WILTSHIRE, X0, SP4 0JQ